Immunochemicals are used to analyze various reactions and components
of molecular mechanism. They are quality products with high
specificity and selectivity and are developed for a wide range of
applications in medical, pharmaceutical, and life science research.
Immunochemicals are used in drug discovery, therapeutics, imaging,
assay components, and as a research tools. They are also used to
develop personalized medicine and protein therapeutics and to
identify new targets to treat various chronic diseases. The global
immunochemicals market is projected to expand at a significant CAGR
during the forecast period owing to increasing research and
development initiatives, rise in government funding in drug discovery
and proteomic research, increase in incidence of chronic diseases,
and rise in collaboration between industries and research institutes.
Furthermore, increase in demand for personalized medicine and protein
therapeutics, increased focus on drugs safety and efficacy, and
identification of new targets for disease treatment are likely to
boost the expansion of the market. However, high cost and stringent
regulatory environment are factors restraining the global
immunochemicals market.
Request Brochure for Detailed Analysis @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43637
The global immunochemicals market can be segmented based on research
area, application, end-user, and geography. Based on research area,
the global immunochemicals market can be classified into autoimmune
diseases, oncology, neurology, infectious diseases, metabolic
diseases, and others. The infectious diseases segment, followed by
the oncology segment, is expected to expand during forecast period
owing a large patient base, increase in demand for targeted therapy,
and rising research and development expenditure. In terms of
application, the global immunochemical market can be segmented into
drug discovery & development, proteomics, and genomics.
The proteomic segment is expected to account for a prominent share of
the market due to utilization of proteomic-based approaches in cancer
profiling and biomarker detection and availability of funds from
various research organizations. Based on end-user, the global
immunochemical market can be divided into pharmaceutical and
biotechnological companies, academic and research institutes, and
others. The pharmaceutical and biotechnological companies segment is
expected to hold significant share during the forecast period due to
higher uptake of immunochemicals in the new drug discovery and
development process.
Enquire for Discount @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43637
In terms of geography, the global immunochemicals market can be
categorized into North America, Europe, Latin America, Asia Pacific,
and Middle East & Africa. The market in North America is
anticipated to be dominant, followed by Europe. Increasing incidence
and prevalence of chronic diseases, well-established health care
infrastructure, presence of a large number of biopharmaceutical
companies and research institutes, increased research and development
expenditure, higher adoption of advanced technologies, and higher
health care spending are likely to propel the expansion of the global
immunochemicals market in North America and Europe.
The market in Asia Pacific is expected to expand at a high CAGR
during the forecast period. The expansion is expected to be driven by
presence of a large patient base suffering from chronic diseases such
as cancer and rheumatoid arthritis in India and China, increasing
demand for personalized medicine, increased government initiatives
toward improving health, and developing health care infrastructure.
The immunochemicals market in Latin America and Middle East &
Africa is anticipated to expand during the forecast period, owing to
increase in investments from major market players in these regions.
Leading players in the global immunochemicals market include Thermo
Fisher Scientific, Inc., Rockland Immunochemicals Inc., Advanced
ImmunoChemical, Inc., Immundiagnostik AG, LGC Biosearch Technologies,
Becton, Dickinson and Company, LAMPIRE Biological Laboratories, Inc.,
Antibodies Inc., and Agilent Technologies.
Request TOC of the Report for Complete Review @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43637
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment